Annotated Medicine and Device Lists


Hydralazine

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 1.4.1 Vasodilators No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
AMP X 1 ML CAJA X 5 AMPULAS
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
El Salvador - 2019 ANTIHIPERTENSIVOS No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS DE ADMINISTRACIÓN PARENTERAL

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Ecuador Essential Medicines List - Ecuador No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 02 ANTIHIPERTENSIVOS No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 1.4.1 Vasodilators No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Ecuador Essential Medicines List - Ecuador No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 30 TBS
El Salvador - 2019 ANTIHIPERTENSIVOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 C. APARELHO CARDIOVASCULAR No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cvs Vasodilators-Antihypertensive No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 C. APARELHO CARDIOVASCULAR No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations

Information Resources: Hydralazine